114 related articles for article (PubMed ID: 20882610)
1. Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas.
Morita N; Wang S; Chawla S; Poptani H; Melhem ER
J Magn Reson Imaging; 2010 Oct; 32(4):803-8. PubMed ID: 20882610
[TBL] [Abstract][Full Text] [Related]
2. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
3. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between magnetic resonance diffusion weighted imaging and cell density in astrocytoma].
Chen J; Xia J; Zhou YC; Xia LM; Zhu WZ; Zou ML; Feng DY; Wang CY
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):309-11. PubMed ID: 15996330
[TBL] [Abstract][Full Text] [Related]
5. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility-weighted imaging in grading brain astrocytomas.
Li C; Ai B; Li Y; Qi H; Wu L
Eur J Radiol; 2010 Jul; 75(1):e81-5. PubMed ID: 19726149
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, microvascular density, and grading of astrocytoma.
Haris M; Husain N; Singh A; Husain M; Srivastava S; Srivastava C; Behari S; Rathore RK; Saksena S; Gupta RK
J Comput Assist Tomogr; 2008; 32(6):955-65. PubMed ID: 19204461
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance dynamic susceptibility-weighted contrast-enhanced perfusion imaging in the diagnosis of posterior fossa hemangioblastomas and pilocytic astrocytomas: initial results.
Kumar VA; Knopp EA; Zagzag D
J Comput Assist Tomogr; 2010; 34(6):825-9. PubMed ID: 21084895
[TBL] [Abstract][Full Text] [Related]
9. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.
Law M; Oh S; Babb JS; Wang E; Inglese M; Zagzag D; Knopp EA; Johnson G
Radiology; 2006 Feb; 238(2):658-67. PubMed ID: 16396838
[TBL] [Abstract][Full Text] [Related]
10. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.
Chawla S; Oleaga L; Wang S; Krejza J; Wolf RL; Woo JH; O'Rourke DM; Judy KD; Grady MS; Melhem ER; Poptani H
J Neuroimaging; 2010 Jan; 20(1):3-8. PubMed ID: 19021846
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors.
Weber MA; Zoubaa S; Schlieter M; Jüttler E; Huttner HB; Geletneky K; Ittrich C; Lichy MP; Kroll A; Debus J; Giesel FL; Hartmann M; Essig M
Neurology; 2006 Jun; 66(12):1899-906. PubMed ID: 16801657
[TBL] [Abstract][Full Text] [Related]
12. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
Young R; Babb J; Law M; Pollack E; Johnson G
J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
[TBL] [Abstract][Full Text] [Related]
13. Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas.
Wang XC; Zhang H; Tan Y; Qin JB; Wu XF; Wang L; Zhang L
J Magn Reson Imaging; 2014 Jun; 39(6):1569-74. PubMed ID: 24987755
[TBL] [Abstract][Full Text] [Related]
14. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
[TBL] [Abstract][Full Text] [Related]
15. MR perfusion-weighted imaging may help in differentiating between nonenhancing gliomas and nonneoplastic lesions in the cervicomedullary junction.
Liu X; Kolar B; Tian W; Germin BI; Huang Y; Hu R; Zhong J; Ekholm S
J Magn Reson Imaging; 2011 Jul; 34(1):196-202. PubMed ID: 21618332
[TBL] [Abstract][Full Text] [Related]
16. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy and interobserver variability of pulsed arterial spin labeling for glioma grading.
Kim MJ; Kim HS; Kim JH; Cho KG; Kim SY
Acta Radiol; 2008 May; 49(4):450-7. PubMed ID: 18415790
[TBL] [Abstract][Full Text] [Related]
18. Differentiating Nonenhancing Grade II Gliomas from Grade III Gliomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.
Alkanhal H; Das K; Rathi N; Syed K; Poptani H
World Neurosurg; 2021 Feb; 146():e555-e564. PubMed ID: 33152494
[TBL] [Abstract][Full Text] [Related]
19. MRI of high-grade astrocytic tumors: early appearance and evolution.
Okamoto K; Ito J; Takahashi N; Ishikawa K; Furusawa T; Tokiguchi S; Sakai K
Neuroradiology; 2002 May; 44(5):395-402. PubMed ID: 12012123
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of dynamic susceptibility contrast perfusion MR imaging at 3T using a standard quadrature head coil and eight-channel phased-array coil with and without SENSE reconstruction.
Lupo JM; Lee MC; Han ET; Cha S; Chang SM; Berger MS; Nelson SJ
J Magn Reson Imaging; 2006 Sep; 24(3):520-9. PubMed ID: 16888776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
